Comment on Shares Of A Biotech Company That DIDN'T Make The Drug That Saved The Ebola-Infected Doctor Are Surging

Shares Of A Biotech Company That DIDN'T Make The Drug That Saved The Ebola-Infected Doctor Are Surging

Dr. Kent Brantly, who had contracted the ebola virus in Liberia, was released from Atlanta's Emory University Hospital after being treated with experimental drug ZMapp. ZMapp was developed by Mapp Biopharmaceutical, a privately held company. It's not to be confused with MAP Pharmceuticals, which was acquired by Allergan in 2013.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News